DSGN — Design Therapeutics, Inc. stock price, charts and financials

QT88Design Therapeutics, Inc.

Design Therapeutics, Inc. (NASDAQ: DSGN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.20
+0.44+3.45%
OverviewShort InterestFilings
DSGNQT88Design Therapeutics, Inc.·NASDAQ
13.20+3.45%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
Jun 09, 2026SC 13GBeneficial ownership statement (passive)
May 18, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 28, 20268-KCurrent report
Apr 28, 202610-QQuarterly report
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 01, 20264Statement of changes in beneficial ownership
Apr 01, 20263Initial statement of beneficial ownership
Apr 01, 20268-KCurrent report
Mar 11, 2026SC 13D/ABeneficial ownership statement (active, amended)
Mar 09, 202610-KAnnual report
Mar 09, 20268-KCurrent report
Mar 09, 2026S-8Registration of employee benefit securities
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 194
Page
▼
/ 8